VDRM Record sales with good fundamentals. Great Technicals :)VDRM does appear to be under accumulation, some targets to the upside have been laid out. This is not financial advice.
−0.0002 USD
4.10 K USD
600.50 K USD
125.60 M
About ViaDerma, Inc.
Sector
Industry
CEO
Chris Ayo Otiko
Headquarters
Marina Del Rey
Founded
2007
FIGI
BBG000JN1H27
ViaDerma, Inc. engages with the manufacturing and sales of pharmaceutical related products. The company was founded on January 11, 2007 and is headquartered in Marina Del Rey, CA.
VDRM FULL DD PACKAGEALL THE DD ON VDRM YOU NEED RIGHT HERE (repost)
2dollarbill Saturday, 08/19/17 10:19:12 AM
Re: None
Post #
26410
of 26411 Go
ALL THE DD ON VDRM YOU NEED RIGHT HERE
FDA approved products that ViaDerma (VDRM) offers:
-skin cancer therapies (Cantrile)
-stem cell therapy product (TetraStem Pl
$VDRM Big money at EOD Big news Friday 52 week High?Projected sales in Japan to exceed 12 million should test 52 week high
Exactly what we neededVery pleased to see new life being breathed into this stock based on the news today
Article - finance.yahoo.com
Fingers crossed for another big move upward next week.
Gonna be a long weekend, have fun and stay safe
Finally!! FDA Number for Premature Ejaculation Drug IS IN! LOS ANGELES, CA--(Marketwired - June 27, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has received its National Drug Code (NDC) 69006-010-00 from the Food and Drug Administration (FDA
MM's shaking out weak handsNothing new here, seen this time and time again with VDRM.
Company gets good news and stock "tanks". Always rebounds and always comes back stronger.
Chart is still strong looking and once we get serious volume rolling in again I think we skyrocket straight to a nickel. FDA approval could push th
Great news today, I believe we see the start of a bull trendWith today's news, the fact that the case has the potential to be dismissed, and FDA approval on the horizon, I think today marks the start of a long bull trend for the rest of the summer.
VDRM continues to honor their word, and continues to show how much they care about investors. Happy to apart
ViaDerma, Inc. Commences First Manufacturing Run and will Meet tLOS ANGELES, CA--(Marketwired - June 12, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has commenced manufacturing of its FDA registered topical antibiotic. ViaDerma, Inc. has complete
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VDRM is 0.0079 USD — it has decreased by −10.34% in the past 24 hours. Watch ViaDerma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange ViaDerma, Inc. stocks are traded under the ticker VDRM.
VDRM stock has fallen by −39.30% compared to the previous week, the month change is a 50.00% rise, over the last year ViaDerma, Inc. has showed a −36.69% decrease.
VDRM reached its all-time high on Dec 11, 2009 with the price of 412.5000 USD, and its all-time low was 0.0008 USD and was reached on Oct 4, 2019. View more price dynamics on VDRM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VDRM stock is 12.68% volatile and has beta coefficient of −0.99. Track ViaDerma, Inc. stock price on the chart and check out the list of the most volatile stocks — is ViaDerma, Inc. there?
Today ViaDerma, Inc. has the market capitalization of 9.62 M, it has decreased by −25.32% over the last week.
Yes, you can track ViaDerma, Inc. financials in yearly and quarterly reports right on TradingView.
VDRM net income for the last quarter is −321.55 K USD, while the quarter before that showed −33.18 K USD of net income which accounts for −869.18% change. Track more ViaDerma, Inc. financial stats to get the full picture.
No, VDRM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ViaDerma, Inc. EBITDA is −145.64 K USD, and current EBITDA margin is 30.89%. See more stats in ViaDerma, Inc. financial statements.
Like other stocks, VDRM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ViaDerma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ViaDerma, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ViaDerma, Inc. stock shows the sell signal. See more of ViaDerma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.